Feb 2026 FDA
Form FDA 483, Inspectional Observations — Auriga Research Private Limited

Inspection of a contract testing laboratory in Bengaluru, India, conducted February 4–6, 2026. Investigators recorded three observations covering microbiological data integrity, out-of-specification investigations and CAPA adequacy, and quality control unit procedures. Obtained through a Freedom of Information Act request.

View PDF → 10 pages · FOIA 2026-3291-CDER-1 · FEI 3019975128

A Form 483 lists observations made by FDA investigators during an inspection. It is not a final agency determination regarding compliance, and a firm may respond to, contest, or have already addressed any observation it contains. Redactions in these documents were applied by the agency prior to release.